Ignite Creation Date:
2024-05-06 @ 2:14 AM
Last Modification Date:
2024-10-26 @ 11:15 AM
Study NCT ID:
NCT01992471
Status:
COMPLETED
Last Update Posted:
2017-12-05
First Post:
2013-11-19
Brief Title:
Multiplex Testing for Breast Cancer Susceptibility A Pilot Study of Subject Preferences for Information and Responses After Testing
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Memorial Sloan Kettering Cancer Center
Study Overview
Official Title:
Multiplex Testing for Breast Cancer Susceptibility A Pilot Study of Subject Preferences for Information and Responses After Testing
Status:
COMPLETED
Status Verified Date:
2017-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to find out what kinds of information people would like to receive from a new kind of genetic testing and how they respond to this new kind of testing
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None